Agency
National Institute of Health (NIH)
Institute
National Center for HIV, Viral Hepatitis, STDS and Tb Prevention (NCHHSTP)
Type
Global HIV/AIDS Non-Research Cooperative Agreements (U2G)
Project #
5U2GPS000811-05
Application #
8121410
Study Section
Special Emphasis Panel (ZPS1-SRC (99))
Project Start
2007-09-29
Project End
2014-09-28
Budget Start
2011-09-29
Budget End
2014-09-28
Support Year
5
Fiscal Year
2011
Total Cost
$24,354,347
Indirect Cost
Name
Aurum Institute for Health Research
Department
Type
DUNS #
653252853
City
Johannesburg
State
Country
South Africa
Zip Code
2193
McCreesh, Nicky; Andrianakis, Ioannis; Nsubuga, Rebecca N et al. (2017) Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda. BMC Infect Dis 17:322
McCreesh, Nicky; Andrianakis, Ioannis; Nsubuga, Rebecca N et al. (2017) Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention - a modelling study. BMC Infect Dis 17:557
Gomez, G B; Dowdy, D W; Bastos, M L et al. (2016) Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis. BMC Infect Dis 16:726
Johnston, Victoria; Cohen, Karen; Wiesner, Lubbe et al. (2014) Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch. J Infect Dis 209:711-20
Johnston, Victoria; Fielding, Katherine; Charalambous, Salome et al. (2012) Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome. PLoS One 7:e36997
Johnston, Victoria; Fielding, Katherine L; Charalambous, Salome et al. (2012) Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program. J Acquir Immune Defic Syndr 61:370-80
Abdool Karim, Salim S; Churchyard, Gavin J; Karim, Quarraisha Abdool et al. (2009) HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 374:921-33